RIBONUCLEOTIDE REDUCTASE ISOLATED FROM HUMAN CELLS - HETEROGENEITY AMONG SOURCES
RIBONUCLEOTIDE REDUCTASE ISOLATED FROM HUMAN CELLS - HETEROGENEITY AMONG SOURCES
复制标题
DOI:
10.1016/0006-2952(78)90134-x
复制
发表时间:
1978-01-01
影响因子:
5.8
通讯作者:
CHENG, YC
中科院分区:
文献类型:
--
作者:
CHANG, CH;CHENG, YC
The amount of ammonium sulfate required to precipitate the ribonucleotide reductase activities derived from histiocytic lymphoma cells obtained from patients or from KB or Connaughton cultured human cells is different than for reductase activity derived from Molt-4F and HeLa S3 cells. The reductase activity of Molt-4F cells sedimented in a sucrose density gradient at a faster rate than the enzyme activity from KB cells. CDP and ADP reductase activity from either source co-sedimented. Enzymes from both cell lines sedimented at a faster rate in the presence of CDP and ATP than in the absence of these compounds, with CDP and ADP reductase still co-sedimenting. The enzymes obtained from the 2 sources have different stabilities at 37.degree.. Hydroxyurea, 1-formylisoquinoline thiosemicarbazone (IQ-1), 1,10-phenanthroline and KCl inhibit the enzyme activity derived from either Molt-4F or KB cells. A difference in the ratio of CDP to ADP reductase activity in Molt-4F and KB cells and a difference between the sensitivities of the CDP and the ADP reductase activities from the same cell line to various concentrations of inhibitors was observed. Ribonucleotide reductase is of potential interest as a target enzyme for cancer chemotherapy.